Acura Financial Statements From 2010 to 2022

ACUR
 Stock
  

USD 0.01  0.00  0.00%   

Acura Pharma financial statements provide useful quarterly and yearly information to potential Acura Pharma Cmn investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Acura Pharma financial statements helps investors assess Acura Pharma's valuation, profitability, and current liquidity needs.
Acura Pharma Cmn does not presently have any fundamental signals for analysis.
.
  
Check Acura Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acura main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Acura financial statements analysis is a perfect complement when working with Acura Pharma Valuation or Volatility modules. It can also supplement various Acura Pharma Technical models . Please continue to the analysis of Acura Pharma Correlation against competitors.

Acura Shares Owned by Institutions Analysis

Acura Pharma's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
More About Shares Owned by Institutions | All Equity Analysis

Current Acura Pharma Shares Owned by Institutions

    
  3.01 %  
Most of Acura Pharma's fundamental indicators, such as Shares Owned by Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acura Pharma Cmn is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Compare to competition

Based on the latest financial disclosure, 3.01% of Acura Pharma Cmn are shares owned by institutions. This is 93.26% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares owned by institutions for all United States stocks is 92.32% higher than that of the company.

Acura Pharma Cmn Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Acura Pharma's current stock value. Our valuation model uses many indicators to compare Acura Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acura Pharma competition to find correlations between indicators driving Acura Pharma's intrinsic value. More Info.
Acura Pharma Cmn is number one stock in current asset category among related companies. It is number one stock in market capitalization category among related companies creating about  0.05  of Market Capitalization per Current Asset. The ratio of Current Asset to Market Capitalization for Acura Pharma Cmn is roughly  21.72 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acura Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acura Pharma's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Acura Pharma's earnings, one of the primary drivers of an investment's value.

About Acura Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Acura Pharma income statement, its balance sheet, and the statement of cash flows. Acura Pharma investors use historical funamental indicators, such as Acura Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Acura Pharma investors may use each financial statement separately, they are all related. The changes in Acura Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Acura Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Acura Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Acura Pharma. Please read more on our technical analysis and fundamental analysis pages.
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acura Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acura Pharma's short interest history, or implied volatility extrapolated from Acura Pharma options trading.

Pair Trading with Acura Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acura Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acura Pharma will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Acura Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acura Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acura Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acura Pharma Cmn to buy it.
The correlation of Acura Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acura Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acura Pharma Cmn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acura Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Acura Pharma Correlation against competitors. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for analysis

When running Acura Pharma Cmn price analysis, check to measure Acura Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acura Pharma is operating at the current time. Most of Acura Pharma's value examination focuses on studying past and present price action to predict the probability of Acura Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acura Pharma's price. Additionally, you may evaluate how the addition of Acura Pharma to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Is Acura Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acura Pharma. If investors know Acura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acura Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Acura Pharma Cmn is measured differently than its book value, which is the value of Acura that is recorded on the company's balance sheet. Investors also form their own opinion of Acura Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acura Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acura Pharma's market value can be influenced by many factors that don't directly affect Acura Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acura Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Acura Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acura Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.